MYGN
Myriad Genetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$3.19
−1.24%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.00x
- Price / sales
- 0.38x
- Price / cash flow
- 39.63x
Enterprise value
- Enterprise value
- $400.4M
- EV / sales
- 0.50x
- EV / EBITDA
- -8.86x
- EV / EBIT
- -4.06x
- Market cap
- $305.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026